Comparison of remimazolam-flumazenil and propofol on emergence profile and cough in nasal surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009152

Enrollment

Registered

2024-01-31

Start date

2024-01-02

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The Remimazolam group maintains general anesthesia by continuous infusion of Remimazolam, while the Propofol group sustains anesthesia through continuous Propofol infusion. Upon completion of t

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study includes patients aged 19 to 65 with a planned sinus or septoplasty surgery due to chronic sinusitis or other related conditions under general anesthesia. The selection criteria are based on the American Society of Anesthesiologists (ASA) physical status classification of 1 or 2.

Exclusion criteria

Exclusion criteria: In cases where difficult airway management is anticipated (Mallampati =3), chronic obstructive pulmonary disease, bronchial asthma, severe heart, kidney, or liver disease, pregnant women, and women of childbearing potential.

Design outcomes

Primary

Measure	Time frame
The frequecny of emergence coguh	—

Secondary

Measure	Time frame
The severity of emergence cough;Time to open the eyes;Time to extubation;Presnece of laryngosapsm;Hypovenetilation (RR<8);Desaturation less than SaO2 95%	—

Countries

Korea, Republic of

Contacts

Public ContactJong Yeop Kim

Ajou University Hospital

kjyeop@ajou.ac.kr+82-31-219-4917

Outcome results